Increased frequencies of Th17 cells in drug eruptions.

[1]  R. Hegazy,et al.  Interleukin 17, interleukin 22 and FoxP3 expression in tissue and serum of non-segmental vitiligo: a case- controlled study on eighty-four patients. , 2013, European journal of dermatology : EJD.

[2]  Y. Teraki,et al.  Possible role of TH17 cells in the pathogenesis of Stevens-Johnson syndrome and toxic epidermal necrolysis. , 2013, The Journal of allergy and clinical immunology.

[3]  J. Ortonne,et al.  Activation of the unfolded protein response in vitiligo: the missing link? , 2012, The Journal of investigative dermatology.

[4]  Q. Mi,et al.  Systemic analyses of immunophenotypes of peripheral T cells in non‐segmental vitiligo: implication of defective natural killer T cells , 2012, Pigment cell & melanoma research.

[5]  T. Shiohara,et al.  Drug-induced hypersensitivity syndrome: recent advances in the diagnosis, pathogenesis and management. , 2012, Chemical immunology and allergy.

[6]  T. Naka,et al.  Dysregulation of melanocyte function by Th17‐related cytokines: significance of Th17 cell infiltration in autoimmune vitiligo vulgaris , 2012, Pigment cell & melanoma research.

[7]  Y. Tokura,et al.  Increased circulating Th17 frequencies and serum IL‐22 levels in patients with acute generalized exanthematous pustulosis , 2011, Journal of the European Academy of Dermatology and Venereology : JEADV.

[8]  N. Pimpinelli,et al.  Dendritic cells: ultrastructural and immunophenotypical changes upon nb-UVB in vitiligo skin , 2011, Archives of Dermatological Research.

[9]  A. Thomsen,et al.  In vitro propagation and dynamics of T cells from skin biopsies by methods using interleukins-2 and -4 or anti-CD3/CD28 antibody-coated microbeads. , 2010, Acta dermato-venereologica.

[10]  M. Tohyama,et al.  Fluctuation of blood and skin plasmacytoid dendritic cells in drug-induced hypersensitivity syndrome. , 2010, The Journal of allergy and clinical immunology.

[11]  D. Bani,et al.  Keratinocyte dysfunction in vitiligo epidermis: cytokine microenvironment and correlation to keratinocyte apoptosis. , 2009, Histology and histopathology.

[12]  R. Abe.  Toxic epidermal necrolysis and Stevens-Johnson syndrome: soluble Fas ligand involvement in the pathomechanisms of these diseases. , 2008, Journal of dermatological science.

[13]  K. Kabashima,et al.  Possible pathogenic role of Th17 cells for atopic dermatitis. , 2008, The Journal of investigative dermatology.

[14]  K. Kabashima,et al.  T cell populations propagating in the peripheral blood of patients with drug eruptions. , 2007, Journal of dermatological science.

[15]  M. Shlomchik,et al.  Epidermal langerhans cell-deficient mice develop enhanced contact hypersensitivity. , 2005, Immunity.

[16]  L. Naldi,et al.  Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. , 2002, Archives of dermatology.

[17]  Y. Tokura,et al.  Characterization of Drug-Specific T Cells in Phenobarbital- Induced Eruption , 2002, The Journal of Immunology.

[18]  H. Pinkus,et al.  Dendritic cell dynamics in progressive depigmentations. Distinctive cytokinetics of -dendritic cells revealed by electron microscopy. , 1972, Archiv fur dermatologische Forschung.

[19]  C. J. Stevenson,et al.  VITILIGO, THYROID DISEASE AND AUTOIMMUNITY , 1968, The British journal of dermatology.